Table 4.

Lymphotoxin-α 252 A>G genotypes and fasting lipid levels in participants not receiving lipid-lowering therapy. Results are means ± SD.

Lipid Levels (mg/dl)	Patients with RA			Healthy Control Population
Lipid Levels (mg/dl)	A/A, n = 34	A/G, n = 27	G/G, n = 13	A/A, n = 25	A/G, n = 38	G/G, n = 21
Total cholesterol	212 ± 32	200 ± 37	197 ± 38	200 ± 32	205 ± 32	197 ± 26
HDL	65 ± 24	64 ± 14	64 ± 13	59 ± 13	62 ± 11	65 ± 15
LDL	129 ± 24	120 ± 33	113 ± 32	124 ± 33	127 ± 26	119 ± 22
Triglycerides	108 ± 41^*	98 ± 36^†	81 ± 24	94 ± 31	94 ± 39	92 ± 47

↵* Adjusted p_{A/A vs G/G} = 0.01 and
↵† p_{A/G vs G/G} = 0.05. HDL: high-density lipoprotein; LDL: low-density lipoprotein.